Gå til indhold
,
Åbn navigation
eller
Gå til kontaktoplysninger
.
Copyright © Inderes 2011 - present. All rights reserved.
Latest
Markeder
Aktieoversigt
Finanskalender
Research
Artikler
InderesTV
Forum
Q&A
Om os
Fulgte selskaber
Team
Indstillinger
Collapse
Sprog
Copyright © Inderes 2011 - present. All rights reserved.
Search site
Log ind
Log ind
for at modtage meddelelser.
Antti Luiro
Analytiker
Dækning
Efecte
LeadDesk
Nightingale Health
Loihde
Springvest
Aiforia Technologies
Qt Group
Witted Megacorp
Seneste indhold
Viser
Alle indholdstyper
Nightingale Health: Market opening will soon be tested
Analyse
29.09.2023
af
Antti Luiro
Nightingale Health
Nightingale Health H2 on Thursday: Eyes kept on the horizon
Analytikerkommentar
22.09.2023
af
Antti Luiro
Nightingale Health
Nightingale’s updated strategy focuses on corporate customers and the public sector
Analytikerkommentar
11.09.2023
af
Antti Luiro
Nightingale Health
Nightingale’s blood analysis introduced in Terveystalo's occupational health services
Analytikerkommentar
31.08.2023
af
Antti Luiro
Nightingale Health
Terveystalo
Aiforia: The journey won't be a straight line
Analyse
28.08.2023
af
Antti Luiro
,
Frans-Mikael Rostedt
Aiforia Technologies
Nightingale Health deepens its strategic cooperation with Terveystalo
Analytikerkommentar
02.07.2023
af
Antti Luiro
Nightingale Health
Nightingale Health: Seeking a commercial recipe for success
Omfattende analyse
05.06.2023
af
Antti Luiro
Nightingale Health
The importance of management
Artikel
24.04.2023
af
Antti Luiro
Faron Pharmaceuticals: BEXMAB study’s good momentum supports valuation
Analyse
17.04.2023
af
Antti Siltanen
,
Antti Luiro
Faron Pharmaceuticals
Nightingale Health: Giving commercialization time to take shape
Analyse
24.03.2023
af
Antti Luiro
Nightingale Health
Vis flere
